Revolution Medicines (RVMD) EBITDA Margin (2019 - 2023)
Revolution Medicines' quarterly EBITDA Margin came in at 21579.78% in Q4 2023, down 2117726.0% year-on-year from N/an in Q4 2022, and down 658.49% quarter-over-quarter from 2845.11% in Q2 2023.
Revolution Medicines has reported EBITDA Margin for 5 years, with the latest figure at 21579.78% in Q4 2023.
- For the quarter ending Q4 2023, EBITDA Margin fell 2117726.0% year-over-year to 21579.78%; the trailing twelve-month figure through Sep 2024 stood at 81972.64% (down 8062093.0% YoY), and the FY2023 full-year result was 3748.21%, down 304129.0% from the prior year.
- EBITDA Margin for Q4 2023 stood at 21579.78%, down from 2845.11% in the prior quarter.
- The five-year high for EBITDA Margin was 79.26% in Q1 2019, with the low at 21579.78% in Q4 2023.
- Average EBITDA Margin over 5 years is 1968.35%, with a median of 402.52% recorded in 2022.
- Year-over-year, EBITDA Margin surged 254813 bps in 2022 and sank 2117726 bps in 2023.
- Tracing RVMD's EBITDA Margin over 5 years: stood at 161.85% in 2019, then plunged by 141 bps to 389.44% in 2020, then tumbled by 44 bps to 559.33% in 2021, then rose by 28 bps to 402.52% in 2022, then sank by 5261 bps to 21579.78% in 2023.
- The last three EBITDA Margin figures came in at 21579.78% (Q4 2023), 2845.11% (Q2 2023), and 1071.53% (Q1 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 18.35% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 17.24% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -21,579.78% |
| Jun 30, 2023 | -2,845.11% |
| Mar 31, 2023 | -1,071.53% |
| Dec 31, 2022 | -402.52% |
| Sep 30, 2022 | -2,280.48% |
| Jun 30, 2022 | -681.10% |
| Mar 31, 2022 | -764.70% |
| Dec 31, 2021 | -559.33% |
| Sep 30, 2021 | -4,828.61% |
| Jun 30, 2021 | -512.01% |
| Mar 31, 2021 | -369.13% |
| Dec 31, 2020 | -389.44% |
| Sep 30, 2020 | -217.61% |
| Jun 30, 2020 | -279.14% |
| Mar 31, 2020 | -182.59% |
| Dec 31, 2019 | -161.85% |
| Sep 30, 2019 | -108.42% |
| Jun 30, 2019 | -85.99% |
| Mar 31, 2019 | -79.26% |